LUTICS 2 MG COM CT BL AL PLAS TRANS PVDC X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1057305100113
  • GGREM 552917080071503
  • Código de barras 7896658033216

O que a fonte publica

Detentor do registro
ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
Princípios ativos
MESILATO DE DOXAZOSINA
Embalagem
2 MG COM CT BL AL PLAS TRANS PVDC X 30
Tipo de produto
Similar
Classe terapêutica
C2A2 - ANTI-HIPERTENSIVOS PURO-AÇÃO PERIFÉRICA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:552917080071503
{
  "name": "LUTICS 2 MG COM CT BL AL PLAS TRANS PVDC X 30",
  "holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
  "stripe": null,
  "barcodes": [
    "7896658033216"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "552917080071503",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "60.659.463/0029-92",
  "priceRegime": "Regulado",
  "productName": "LUTICS",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "2 MG COM CT BL AL PLAS TRANS PVDC X 30",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "41.74",
    "icms-12": "47.43",
    "icms-17": "50.29",
    "icms-18": "50.90",
    "icms-19": "51.53",
    "icms-20": "52.18",
    "icms-21": "52.84",
    "icms-22": "53.51",
    "icms-23": "54.21",
    "icms-17.5": "50.59",
    "icms-19.5": "51.85",
    "icms-20.5": "52.50",
    "icms-22.5": "53.86",
    "icms-12-alc": "46.86",
    "icms-17-alc": "49.69",
    "icms-18-alc": "50.29",
    "icms-19-alc": "50.91",
    "icms-20-alc": "51.55",
    "icms-21-alc": "52.20",
    "icms-22-alc": "52.87",
    "icms-23-alc": "53.56",
    "withoutTaxes": "41.24",
    "icms-17.5-alc": "49.99",
    "icms-19.5-alc": "51.23",
    "icms-20.5-alc": "51.87",
    "icms-22.5-alc": "53.21"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "MESILATO DE DOXAZOSINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "57.53",
    "icms-12": "65.38",
    "icms-17": "69.32",
    "icms-18": "70.16",
    "icms-19": "71.03",
    "icms-20": "71.92",
    "icms-21": "72.83",
    "icms-22": "73.76",
    "icms-23": "74.72",
    "icms-17.5": "69.73",
    "icms-19.5": "71.47",
    "icms-20.5": "72.37",
    "icms-22.5": "74.24",
    "icms-12-alc": "64.78",
    "icms-17-alc": "68.69",
    "icms-18-alc": "69.52",
    "icms-19-alc": "70.38",
    "icms-20-alc": "71.26",
    "icms-21-alc": "72.16",
    "icms-22-alc": "73.09",
    "icms-23-alc": "74.04",
    "withoutTaxes": "57.01",
    "icms-17.5-alc": "69.11",
    "icms-19.5-alc": "70.82",
    "icms-20.5-alc": "71.71",
    "icms-22.5-alc": "73.56"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "MESILATO DE DOXAZOSINA"
  ],
  "therapeuticClass": "C2A2 - ANTI-HIPERTENSIVOS PURO-AÇÃO PERIFÉRICA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1057305100113",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "C2A2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:552917080071503"